Cite
MLA Citation
P. Neumair et al.. “Erlotinib has comparable clinical efficacy to chemotherapy in pretreated patients with advanced non-small cell lung cancer (NSCLC): A propensity-adjusted, outcomes research-based study.” Lung cancer, vol. 100, 2016, pp. 38–44. http://access.bl.uk/ark:/81055/vdc_100035793494.0x00003c